Evidence map›Paper›PMID 40640719›Full record

ArticleBMC bioinformatics2025

EDRMM: enhancing drug recommendation via multi-granularity and multi-attribute representation.

Feiyan Liu, Wenhao Wang, Jiawei Zheng, Yibo Xie, Xiaoli Wang, Dongxiang Zhang

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Feiyan Liu *School of Informatics, Xiamen University, Xiamen, 361000, Fujian, China.
Wenhao Wang *School of Informatics, Xiamen University, Xiamen, 361000, Fujian, China.
Jiawei ZhengSchool of Informatics, Xiamen University, Xiamen, 361000, Fujian, China.
Yibo XieSchool of Informatics, Xiamen University, Xiamen, 361000, Fujian, China.
Xiaoli WangSchool of Informatics, Xiamen University, Xiamen, 361000, Fujian, China. xlwang@xmu.edu.cn.
Dongxiang ZhangCollege of Computer Science and Technology, Zhejiang University, Hangzhou, 310027, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDrug recommendation is a crucial application of artificial intelligence in medical practice. Although many models have been proposed to solve this task, two challenges remain unresolved: (i) most existing models use all historical visits as input, overlooking fine-grained correlations between historical and current information; (ii) Electronic Health Records (EHRs) are underutilized, with only partial information considered to describe patient conditions. To tackle the challenges, we propose a novel drug recommendation model, denoted by EDRMM, which incorporates multi-granularity and multi-attribute information into representation learning. We develop a longitudinal attribute-level history selection mechanism to effectively identify fine-grained historical information that is highly relevant to a patient's current clinical conditions. We analyze the impact of key Electronic Health Record (EHR) attributes, demonstrating that incorporating such attributes into patient representations can further boost performance. We also design an adaptive global Drug-Drug Interaction (DDI) risk regularization term for the DDI loss function to better balance accuracy and safety during training.

resultsExperimental results show that our model achieves state-of-the-art performance on a widely used MIMIC-III dataset.

conclusionsEDRMM overcomes two key drug recommendation limitations through three innovations: (1) Dynamic attribute-level history selection, which retrieves relevant features and filters out noise, (2) The integration of multi-attribute EHR with attribute-specific encoding strategies to generate comprehensive patient representations, and (3) Hybrid optimization balancing accuracy and safety via adaptive DDI regularization. The combination of these three innovations enables the proposed EDRMM to achieve the best recommendation performance on the MIMIC-III dataset.

Indexed as

Artificial IntelligenceAlgorithmsDrug InteractionsElectronic Health RecordsHumansDrug recommendationElectronic health recordRepresentation learning

Identifiers

PMID40640719
PMCPMC12243427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.